Voice characteristics of people with Parkinson’s Disease (PwP): an overview on baseline vocal characteristics and guidelines for therapeutic singing (IR)

Ang, Mei Foong

QR Code Link :
Type :	article
Subject :	M Music
ISSN :	2600-9366
Main Author :	Ang, Mei Foong
Title :	Voice characteristics of people with Parkinson’s Disease (PwP): an overview on baseline vocal characteristics and guidelines for therapeutic singing (IR)

Place of Production :	Universiti Pendidikan Sultan Idris
Year of Publication :	2018
PDF Full Text :	Login required to access this item.

Abstract :

Parkinson’s Disease (PD) is a chronic neurodegenerative disease in which the symptoms of the disease are worsen over time. Core symptoms of the disease are such as tremor-at-rest, rigidity, postural instability, and bradykinesia. Apart from these motor-problems, other problems such as sleep disorder, sensory abnormalities, neuropsychiatric disorders also exist. In addition to the motor-problems, latest literature documented 80-90% of the people with Parkinson’s Disease (PwP) are prone to develop voice impairment known as Parkinsonian Dysarthria, when symptoms deteriorate, causing loss of communication, difficulties in swallowing and breathing that are psychologically devastating and life threatening. Growing research in music therapy (MT) and music-based rehabilitative activities worldwide documented positive effects on PwP. A local research using therapeutic singing as rehabilitative model at the Malaysian Parkinson’s Disease Association (MPDA) also have reported positive benefits in improving vocal problems in the Malaysian PwP. In this research, some primary and preliminary data on the vocal characteristic, including baseline vocal loudness (VL), pitch range (PR) and respiratory rate (RR) were obtained among 22 local PwP prior to examining effects of singing on PwP. Findings of this study showed that the PwP speak softer than the normal accepted range. The findings also showed that they have tendency to develop rapid breathing, and their average pitch range while singing is limited within the range of G#3 – B4. These findings can further propose guidelines for voice rehabilitation models based on the preliminary voice characteristics concluded in this study.

References

1. Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999). Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. International Journal of Geriatric Psychiatry, 14(10), 866–874. https://doi.org/10.1002/(SICI)1099-1166(199910)14:10<866::AID- GPS38>3.0.CO;2-Z 2. Atkinson-Clement, C., Sadat, J., & Pinto, S. (2015). Behavioral treatments for speech in Parkinson’s disease: meta-analyses and review of the literature. Neurodegenerative Disease Management, 5(3), 233–248. https://doi.org/10.2217/nmt.15.16 3. Bennett, G. (2017). The science of singing : A voice lesson from anatomy and physiology (pp. 0–15). Cedarville University. Retrieved from https://digitalcommons.cedarville.edu/research_scholarship_symposium/2017/ podium_presentations/1/ 4. Branchi, I., D’Andrea, I., Armida, M., Cassano, T., Pezzola, A., Potenza, R. L., Morgese, M. G, Popoli, P., Alleva, E. (2008). Nonmotor symptoms in Parkinson’s disease: Investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. Journal of Neuroscience Research, 86(9), 2050–2061. https://doi.org/10.1002/jnr.21642 5. Buetow, S. A., Talmage, A., McCann, C., Fogg, L., & Purdy, S. (2014). Conceptualizing how group singing may enhance quality of life with Parkinson’s disease. Disability and Rehabilitation, 36(5), 430–433. https://doi.org/10.3109/09638288.2013.793749 6. Cacciatore, F. M., Simone, D. De, Patrocinio, D., & Sallustio, V. (2012). Adverse drug reaction to dopamine agonists (DA) or appearance of a typical sign of Parkinson’s Disease induced by DA. Basal Ganglia, 2(3), e1–e87. https://doi.org/10.1016/j.baga.2012.10.001 7. Clark, J. P., Adams, S. G., Dykstra, A. D., Moodie, S., & Jog, M. (2014). Loudness perception and speech intensity control in Parkinson’s disease. Journal of Communication Disorders, 51, 1–12. https://doi.org/10.1016/j.jcomdis.2014.08.001 8. Dyduch, A., & Załuska, M. (2014). Depression in Parkinson’s disease: the effectiveness and risk of pharmacotherapy. Clinical review. Psychogeriatrics : The Official Journal of the Japanese Psychogeriatric Society, 1–7. https://doi.org/10.1111/psyg.12078 9. Elefant, C., Baker, F. a, Lotan, M., Lagesen, S. K., & Skeie, G. O. (2012). The Effect of Group Music Therapy on Mood, Speech, and Singing in Individuals with Parkinson’s Disease -- A Feasibility Study. Journal of Music Therapy, 49(3), 278–302. https://doi.org/10.1093/jmt/49.3.278 10. Elefant, C., Lotan, M., Baker, F. a., & Skeie, G. O. (2012). Effects of music therapy on facial expression of individuals with Parkinson’s disease: A pilot study. Musicae Scientiae, 16(3), 392–400. https://doi.org/10.1177/1029864912458917 11. Evans, C., Canavan, M., Foy, C., Langford, R., & Proctor, R. (2012). Can group singing provide effective speech therapy for people with Parkinson’s disease? Arts & Health, 4(1), 83–95. https://doi.org/10.1080/17533015.2011.584883 12. Fogg-Rogers, L., Buetow, S., Talmage, A., McCann, C. M., Leao, S. H. S., Tippett, L., Leung, J., McPherson, K. M., Purdy, S. C. (2015). Choral singing therapy following stroke or Parkinson’s disease: An exploration of participants’ experiences. Disability and Rehabilitation, 8288(November), 1–11. https://doi.org/10.3109/09638288.2015.1068875 13. Haneishi, E. (2001). Effects of a music therapy voice protocol on speech intelligibility, vocal acoustic measures, and mood of individuals with Parkinson’s disease. Journal of Music Therapy, 38(4), 273–290. https://doi.org/10.1093/jmt/38.4.273 14. Jankovic, J. (2008). Parkinson’s disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery & Psychiatry, 79(4), 368–376. https://doi.org/10.1136/jnnp.2007.131045 15. Jenkinson, C., Peto, V., Fitzpatrick, R., Greenhall, R., Hyman, N. (1995) Self- reported Functioning and Well-being in Patients with Parkinson's Disease: Comparison of the Short-form Health Survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39). Age and Ageing, 24, 505-509. 16. Lim, S.-Y., Fox, S. H., & Lang, A. E. (2009). Overview of the extranigral aspects of Parkinson disease. Archives of Neurology, 66(2), 167–172. https://doi.org/10.1001/archneurol.2008.561 17. Lim, S.-Y., Puvanarajah, S., Lee, M. K., Chee, K. Y., Viswanathan, S., Tan, A. H., Chong, K. T., Azrin, K. (2012). 2012 Consensus Guidelines for the Treatment of Parkinson’s Disease. 18. Meireles, J., & Massano, J. (2012). Cognitive impairment and dementia in Parkinson’s disease: Clinical features, diagnosis, and management. Frontiers in Neurology, MAY(May), 1–16. https://doi.org/10.3389/fneur.2012.00088 19. Miller, N., Deane, K. H. O., Jones, D., Noble, E., & Gibb, C. (2011). National survey of speech and language therapy provision for people with Parkinson’s disease in the United Kingdom: Therapists’ practices. International Journal of Language & Communication Disorders / Royal College of Speech & Language Therapists, 46(2), 189–201. https://doi.org/10.3109/13682822.2010.484849 20. Miller, N., Noble, E., Jones, D., & Burn, D. (2006). Life with communication changes in Parkinson’s disease. Age and Ageing, 35(3), 235–239. https://doi.org/10.1093/ageing/afj053 21. Pabon, P., Stallinga, R., Södersten, M., & Ternström, S. (2014). Effects on vocal range and voice quality of singing voice training: The classically trained female voice. Journal of Voice, 28(1), 36–51. https://doi.org/10.1016/j.jvoice.2013.06.005 22. Pacchetti, C., Mancini, F., Aglieri, R., Fundarò, C., Martignoni, E., & Nappi, G. (2000). Active music therapy in Parkinson’s disease: An integrative method for motor and emotional rehabilitation. Psychosomatic Medicine, 62, 386–393. https://doi.org/10.1097/00006842-200005000-00012 23. Pagonabarraga, J., Kulisevsky, J., Strafella, A. P., & Krack, P. (2015). Apathy in Parkinson’s disease: Clinical features, neural substrates, diagnosis, and treatment. The Lancet Neurology, 14(5), 518–531. https://doi.org/10.1016/S1474-4422(15)00019-8 24. Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-dowsey, P., & Auzou, P. (2004). Review treatments for dysarthria in Parkinson ’ s disease. Neurology, 3(September), 547–556. 25. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, K. R., & Piccini, P. (2010). Parkinson’s disease symptoms: The patient’s perspective. Movement Disorders, 25(11), 1646–1651. https://doi.org/10.1002/mds.23135 26. Ramig, L., & Fox, C. (2007). Speech disorders in Parkinson’s disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment (LSVT). Parkinson’s Disease Foundation News and Review. 27. Ramig, L. O., Fox, C., & Sapir, S. (2007). Speech disorders in Parkinson’s disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment (LSVT). Handbook of Clinical Neurology (Vol. 83, pp. 385–399). https://doi.org/10.1016/S0072- 9752(07)83017-X 28. Richardson, K., Sussman, J. E., Stathopoulos, E. T., & Huber, J. E. (2014). The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: A preliminary analysis. Journal of Communication Disorders, 52, 44–64. https://doi.org/10.1016/j.jcomdis.2014.09.004 29. Rutten, S., Ghielen, I., Vriend, C., Hoogendoorn, A. W., Berendse, H. W., Leentjens, A. F. G., … van den Heuvel, O. A. (2014). Anxiety in Parkinson’s disease: Symptom dimensions and overlap with depression and autonomic failure. Parkinsonism and Related Disorders. https://doi.org/10.1016/j.parkreldis.2014.11.019 30. Sataloff, R. T. (2015). Book Review: Singing and Science: Body, Brain and Voice. Journal of Voice, 29(1), e1. https://doi.org/10.1016/j.jvoice.2014.06.010 31. Schulz, G. M., & Grant, M. K. (2000). Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson’s disease: A review of the literature. Journal of Communication Disorders, 33, 59–88. https://doi.org/10.1016/S0021-9924(99)00025-8 32. Schulz, G. M., Greer, M., & Friedman, W. (2000). Changes in vocal intensity in Parkinson’s disease following pallidotomy surgery. Journal of Voice:Official Journal of the Voice Foundation, 14(4), 589–606. https://doi.org/10.1016/S0892-1997(00)80015-6 33. Scott, S., & Caird, F. I. (1983). Speech therapy for Parkinson’ s disease. Journal of Neurology, Neurosurgery, and Psychiatry, 46(October 1982), 140–144. Retrieved from http://jnnp.bmj.com/content/46/2/140.full.pdf+html 34. Tanday, S. (2016). Feature How the power of singing is helping patients to breathe again. The Lancet Respiratory, 2600(16), 2600. https://doi.org/10.1016/S2213- 2600(16)00002-3 35. Wertheimer, J., Gottuso, A. Y., Nuno, M., Walton, C., Duboille, A., Tuchman, M., & Ramig, L. (2014). The impact of STN deep brain stimulation on speech in individuals with Parkinson’s disease: The patient’s perspective. Parkinsonism and Related Disorders, 20(10), 1065–1070. https://doi.org/10.1016/j.parkreldis.2014.06.010

This material may be protected under Copyright Act which governs the making of photocopies or reproductions of copyrighted materials.
You may use the digitized material for private study, scholarship, or research.

Back to previous page